Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Peripartum Cardiomyopathy, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program. Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School’s Beth Israel Hospital, Dr. Post received her master’s degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital. Dr. Post joined the Johns Hopkins faculty in 1997. Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Post also leads Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-studies. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years. Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation. She has over 350 peer-reviewed research publications. Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty. She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow. She was co-chair of the Johns Hopkins University Committee on the Biomedical Scientific Workforce. Dr. Post is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. Her top areas of expertise are Atherosclerosis, Coronary Heart Disease, Carotid Artery Disease, Hormone Replacement Therapy (HRT), and Aortic Valve Replacement.

Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Dr. Joao Lima is a professor of medicine, radiology and epidemiology at the Johns Hopkins School of Medicine. His pioneering work in cardiac imaging using advanced MRI, CT and echocardiography has led to noninvasive techniques for predicting cardiovascular disease and calculating its extent, as well as measuring the effectiveness of modern cardiac treatments. He holds numerous patents on devices and methods for cardiac imaging and image-guided therapies. Dr. Lima graduated medical school at the University of Bahia, Brazil. He completed his cardiology fellowship at Johns Hopkins and spent two years on the faculty of the University of Pennsylvania before returning to Hopkins as a faculty member in 1992. A long-time investigator with the Multi-Ethnic Study of Atherosclerosis (MESA), Dr. Lima is credited with more than 175 articles out of that study and nearly 575 publications over his career. He is associate editor of Journal of the American College of Cardiology and serves on the editorial board of the Italian Journal of Cardiology while reviewing for other journals including the New England Journal of Medicine, Circulation and Annals of Internal Medicine. Dr. Lima has been invited to present his research throughout the Americas, Europe and Asia. Dr. Lima is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Heart Attack, Apoplexy, Heart Failure, and Bone Marrow Aspiration.

Dr. Chiadi Ndumele is the Director of Obesity and Cardiometabolic Research, Director of the Heart Failure Prevention Program and Associate Professor of Medicine and Epidemiology in the Division of Cardiology at Johns Hopkins University. Dr. Ndumele is a preventive cardiologist with doctorate level training in epidemiology, who leads a research program related to characterizing the relationship of obesity and cardiometabolic risk factors with the development of cardiovascular disease, with a particular focus on heart failure risk, and to refining strategies for cardiovascular disease prevention. His work additionally addresses the impact of social determinants of health on cardiometabolic risk factors and downstream cardiovascular outcomes. Dr. Ndumele received his M.D. from Harvard University and his Internal Medicine training at Brigham and Women’s Hospital, where he also served as Chief Medical Resident. He subsequently trained in Cardiology at Johns Hopkins University, where he was also Chief Cardiology Fellow in his final year and where he also received his MHS and PhD in Epidemiology. Dr. Ndumele’s research has been supported by multiple grants from the NIH, Robert Wood Johnson Foundation and the American Heart Association (AHA). He is Chair of the Council on Lifestyle and Cardiometabolic Health of the AHA, Past Chair of the AHA Obesity Committee, and Co-Chair of the AHA Cardiovascular-Kidney-Metabolic Health Initiative. Dr. Ndumele is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), and Metabolic Syndrome.

Dr. Seamus Whelton MD, MPH, is an Associate Professor of Cardiology and member of the Ciccarone Center for the Prevention of Cardiovascular Disease. His primary clinical and research expertise includes the pathogenesis, risk prediction, prevention, and treatment of atherosclerotic cardiovascular disease with an emphasis on the identification of coronary artery calcium via cardiac CT scanning. He is Director of the Advanced Subclinical Atherosclerosis Clinic, which focuses on the treatment of patients with incidentally discovered coronary artery calcium detected by CT imaging. He is also an expert on the pathogenesis, epidemiology, and risk factors for aortic valve calcification. He has led pioneering research to describe the use aortic valve calcification to predict the risk of aortic stenosis. Dr. Whelton has published more than 130 peer reviewed manuscripts, multiple book chapters, and has been an invited lecturer at both national and international conferences. He is an Associate Editor at the Journal of Cardiovascular Computed Tomography and the American Journal of Preventive Cardiology. He is a member of the American College of Cardiology Prevention of Cardiovascular Disease Leadership Council. He has been the Principal Investigator on grants from the National Institutes of Health and American Heart Association. Dr. Whelton received his undergraduate degree at Princeton University. He then completed a Masters of Public Health in Epidemiology at the Tulane University School of Public Health and Tropical Medicine followed by his Doctor of Medicine degree from the Tulane University School of Medicine. He subsequently completed a post-doctoral fellowship at the Welch Center for Prevention, Epidemiology and Clinical Research at the Johns Hopkins Bloomberg School of Public Health and then completed a fellowship in Cardiology at the Johns Hopkins School of Medicine before joining the Cardiology Faculty at Johns Hopkins in 2017. Videos Dr. Seamus Whelton. Dr. Whelton is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Apoplexy, Coronary Heart Disease, Pacemaker Implantation, and Heart Bypass Surgery.

Stephen Pollock is a Cardiologist in Towson, Maryland. Dr. Pollock is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Angina, and Apoplexy.

Paul Gurbel is a Cardiologist in Baltimore, Maryland. Dr. Gurbel is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Acute Coronary Syndrome, Coronary Heart Disease, Heart Attack, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Vikas Kalra is a Cardiac Electrophysiologist and a Cardiologist in Towson, Maryland. Dr. Kalra is rated as an Experienced provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atrial Fibrillation, Bidirectional Tachycardia, Catecholaminergic Polymorphic Ventricular Tachycardia, Pacemaker Implantation, and Cardiac Ablation. Dr. Kalra is currently accepting new patients.

Jaideep Patel is a Cardiologist in Baltimore, Maryland. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, and Heart Failure.

Dr. Reed David Riley is an assistant professor of medicine at the Johns Hopkins University School of Medicine and chief of cardiology at the Greater Baltimore Medical Center. Dr. Riley received his undergraduate degree from Duke University. He earned a medical degree from The Johns Hopkins University School of Medicine and completed a residency at Johns Hopkins Hospital. Prior to joining Johns Hopkins in 2007, Dr. Riley was a cardiology fellow at Duke University and staff cardiologist at Sinai Hospital of Baltimore. He is currently also a teaching attending on the Osler Medical Service’s Barker Firm at the Johns Hopkins Hospital. Dr. Riley is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Heart Attack, Atrial Fibrillation, Apoplexy, and Angina.

Dr. Shilpi Ahmed’s areas of clinical expertise include cardiology and internal medicine. She earned her M.B.B.S. from Mymensingh Medical College. She completed a residency in cardiology at Nagasaki University and a residency in internal medicine at Medical College of Georgia – Augusta University. She performed a fellowship in cardiovascular disease at Medical College of Georgia – Augusta University. Dr. Ahmed is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. Her top areas of expertise are Sitosterolemia, Atrial Fibrillation, Atherosclerosis, and Coronary Heart Disease.

Dr. Jennifer Tanio is a cardiologist at the Johns Hopkins Health Care and Surgery Center at Green Spring Station. Dr. Tanio received her B.A. from Johns Hopkins University and her M.D. from the University of Pennsylvania School of Medicine. She completed her residency at the University of Pennsylvania and pursued cardiology fellowships at the University of Pennsylvania and the Johns Hopkins University School of Medicine. Dr. Tanio worked in private practice before joining the Johns Hopkins cardiology faculty. Dr. Tanio’s clinical expertise includes preventive cardiology and heart disease. Dr. Tanio is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. Her top areas of expertise are Mitral Valve Prolapse, Heart Attack, Atherosclerosis, and Coronary Heart Disease.

Tala K Al-Talib, M.D. is a cardiologist in Baltimore, MD. She is the Medical Director of Johns Hopkins Medicine – Cardiology at Johns Hopkins Greenspring Station. Dr. Al-Talib’s clinical areas of focus are in general and preventative cardiology. She specializes in cardiovascular disease in women, with a particular interest in cardiovascular risk assessment and treatment of cardiac conditions in women with breast cancer or other oncological history. She was integral in the establishment of the Preventative Cardiology Program to Improve Heart Health for Female Breast Cancer Survivors, a collaborative effort to detect asymptomatic cardiovascular disease and ultimately prevent cardiovascular events in this patient group. After receiving her medical degree from University of Maryland School of Medicine, Dr. Al-Talib completed her residency in Internal Medicine at the University of Maryland Medical Center, where she was Chief Medical Resident. She completed her post-doctoral fellowship in cardiovascular medicine at University of Maryland Medical Center. In addition to her clinical practice, Dr. Al-Talib also serves as an inpatient echocardiographer at Bayview Medical Center, performing transesophageal echo (TEE) and cardioversions and attends on the inpatient cardiology services. Videos Red Chair SeriesDr. Tala Al-Talib. Dr. Al is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. Her top areas of expertise are Heart Attack, Cardiomyopathy Due to Anthracyclines, Doxorubicin-Induced Cardiomyopathy, and Apoplexy.

Dr. Elizabeth Ratchford is a Professor of Clinical Medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include vascular medicine. Dr. Ratchford serves as the director of the Johns Hopkins Center for Vascular Medicine. Dr. Ratchford received her M.D. from the Yale University School of Medicine. She completed her residency at New York-Presbyterian Hospital/Columbia University. Her research interests include peripheral artery disease, fibromuscular dysplasia, and cardiovascular disease prevention among firefighters. Dr. Ratchford has been recognized by several honors, including the Merck Book Award from Yale University School of Medicine. She serves on the editorial board of the journal Vascular Medicine as editor of the Patient Page Section. She is currently the President of the Society for Vascular Medicine. Dr. Ratchford is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. Her top areas of expertise are Superficial Thrombophlebitis, Carotid Artery Disease, Peripheral Artery Disease, and Deep Vein Thrombosis.

Dr. Gary Gerstenblith is professor of medicine and director of clinical trials in the Johns Hopkins Medicine Division of Cardiology. He also serves as attending physician in r the Cardiology care Unit. Dr. Gerstenblith earned his undergraduate degree from New York University and his medical degree from the University of Pennsylvania School of Medicine. After working at the National Institute on Aging and the National Institutes of Health (NIH) and completing a fellowship at Jackson Memorial Hospital in Miami, Dr. Gerstenblith joined the faculty of the Johns Hopkins University School of Medicine. Dr. Gerstenblith conducts clinical trials in patients with cardiovascular disease. His research interests include the impact of cardiovascular aging on cardiac structure and function, and the use of stem cells to repair damaged cardiac muscle. He has published nearly 250 articles and book chapters and has been a referee for numerous journals including Circulation, The New England Journal of Medicine and The Journal of the American College of Cardiology. Dr. Gerstenblith is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Heart Attack, Atherosclerosis, Coronary Heart Disease, Apoplexy, and Percutaneous Coronary Intervention (PCI).

Pamela Ouyang is a Cardiologist in Baltimore,, Maryland. Dr. Ouyang is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. Her top areas of expertise are Atherosclerosis, Menopause, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Attack, and Hormone Replacement Therapy (HRT).

Daniel Ambinder is an Interventional Cardiologist and a Cardiologist in Towson, Maryland. Dr. Ambinder is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Ventricular Fibrillation, Angioplasty, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Ambinder is currently accepting new patients.

Syed Zaidi is an Interventional Cardiologist and a Cardiologist in Towson, Maryland. Dr. Zaidi is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Coronary Heart Disease, Heart Attack, Aortic Valve Stenosis, Angioplasty, and Aortic Valve Replacement. Dr. Zaidi is currently accepting new patients.